Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | TYMS | P04818 | 4/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10829100 | 0.81 | TSHR (0.48) | TSHRTYMSALOX15TDP1MEN1 | |
| SCHEMBL125842 | 0.80 | TSHR (0.72) | TSHRALOX15TDP1ALDH1A1 | |
| SCHEMBL127148 | 0.79 | TSHR (0.46) | TSHRTYMSALOX15TDP1 | |
| SCHEMBL128103 | 0.79 | TYMS (0.41) | TSHRTYMSALOX15TDP1ALDH1A1 | |
| SCHEMBL127158 | 0.77 | TYMS (0.46) | TSHRTYMSALOX15TDP1ALDH1A1 | |
| SCHEMBL148025 | 0.77 | TYMS (0.62) | TYMSALOX15TDP1ALDH1A1MEN1 | |
| SCHEMBL9111658 | 0.76 | TYMS (0.50) | TSHRTYMSALOX15TDP1ALDH1A1 | |
| SCHEMBL855919 | 0.76 | TSHR (0.46) | TSHRTYMSALOX15TDP1ALDH1A1 | |
| SCHEMBL29462451 | 0.76 | TSHR (0.46) | TSHRTYMSALOX15TDP1ALDH1A1 | |
| SCHEMBL502543 | 0.74 | TYMS (0.48) | TSHRTYMSALOX15TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150123090-A1 | METHOD FOR THE DEPOSITION OF AN ORGANIC MATERIAL | BASF SE (DE) | 2015-05-07 | — | — | US | disclosed |
| US-20150123090-A1 | METHOD FOR THE DEPOSITION OF AN ORGANIC MATERIAL | BASF SE (DE) | 2015-05-07 | — | — | US | disclosed |
| WO-2013164761-A1 | METHOD FOR THE DEPOSITION OF AN ORGANIC MATERIAL | BASF SE (DE) | 2013-11-07 | — | — | WO | disclosed |
| EP-2532663-A1 | Naphthalenecarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2012-12-12 | — | — | EP | disclosed |
| US-8309728-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2012-11-13 | — | — | US | disclosed |
| US-8309728-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2012-11-13 | — | — | US | disclosed |
| US-20120059168-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120059168-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-8084603-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2011-12-27 | — | — | US | disclosed |
| US-8084603-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2011-12-27 | — | — | US | disclosed |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
| WO-2007074137-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2007-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059168-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | TST, NANS, NCDN | TSHR 3872/4885TYMS 328/4885ALOX15 2912/4885 |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | ADSL, ALAD, EED | TSHR 4522/4885TYMS 173/4885ALOX15 2871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.